MedX Health Corp (CVE:MDX – Get Free Report)’s stock price fell 20% during mid-day trading on Thursday. The company traded as low as C$0.04 and last traded at C$0.04. 276,100 shares changed hands during mid-day trading, an increase of 221% from the average session volume of 86,096 shares. The stock had previously closed at C$0.05.
MedX Health Stock Performance
The firm has a fifty day simple moving average of C$0.05 and a 200 day simple moving average of C$0.05. The company has a market cap of C$13.12 million, a PE ratio of -2.00 and a beta of 0.14.
MedX Health Company Profile
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment.
Featured Articles
- Five stocks we like better than MedX Health
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for MedX Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedX Health and related companies with MarketBeat.com's FREE daily email newsletter.
